our product list

Transcript

our product list
clarochem
ireland limited
The manufacturing units of CFM group
Our APIs
COSMA SpA
AMISULPRIDE
ATENOLOL
CARPROFEN
CETIRIZINE 2HCl
D,L-CLOPERASTINE FENDIZOATE / HCl
GLICLAZIDE
HYDROXYZINE HCl/PAMOATE
KETOPROFEN
LABETALOL HCl
METOCLOPRAMIDE
MILNACIPRAN HCl
PANTETHINE 80%
PROPRANOLOL HCl
PYRANTEL PAMOATE
RANOLAZINE
SULFINPYRAZONE
TELMISARTAN
TIANEPTINE SODIUM
TORSEMIDE
anti-psychotic
anti-hypertensive
anti-inflammatory
anti-histaminic
anti-tussive
anti-diabetic
anti-histaminic
anti-inflammatory
anti-hypertensive
anti-emetic
anti-fibromyalgic
dietary supplement, anti-hyperlipidemic
anti-hypertensive
anti-helminthic
anti-anginal
anti-gout
anti-hypertensive
anti-depressant
diuretic
AMSA SpA
BROMHEXINE HCl
D,L-DROPROPIZINE
ETODOLAC
FLECAINIDE ACETATE
GLIPIZIDE
GLYCOPYRROLATE METHYLBROMIDE
LURASIDONE HCl
MEMANTINE HCl
MELOXICAM
METOCLOPRAMIDE BASE/HCl/2HCl
OXANTEL PAMOATE
mucolytic
anti-tussive
anti-inflammatory
anti-arrhythmic
anti-diabetic
anti-cholinergic
anti-psychotic
anti-Alzheimer
anti-inflammatory
anti-emetic
anti-helminthic
Clarochem Ireland Ltd
EU-GMP
CEP
EDMF
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
anti-inflammatory
dietary supplement
non-systemic antibiotic
anti-inflammatory
anti-tussive
Products under development:
Levomilnacipran
Mirabegron
Amantadine HCl
Calcium Pantetheine-S-Sulfonate 70%
Droxidopa
anti-depressive
overactive bladder disease
Parkinson's disease; anti-viral
skin lightening cosmetic
neurogenic orthostatic hypotension
V
JDMF
V
V
V
V
V
V
V
V
EU-GMP
CEP
EDMF
USDMF
JDMF
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
V
EU-GMP
DEXKETOPROFEN TROMETAMOL
PHOSPHORYLCOLAMINE
RIFAXIMIN
KETOPROFEN LYSINATE
LEVODROPROPIZINE
USDMF
V
CEP
EDMF
V
V
V
V
V
V
V
V
V
The suppliability of any of the above products is strictly subject to any applicable patent or intellectual property right held by third parties.
For more information, please contact our commercial department : tel. +39-023925326, fax +39-0239219957, email [email protected]
V
V
V
V
USDMF
V
JDMF

Documenti analoghi